Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2835-2846

  Kurkjian, Cathryn ^a   Hollifield, Melissa ^a,c   Lines, J Louise ^a   Rogosky, Amy ^a   Empey, Kerry M ^b,d   Qureshi, Mahboob ^a,e   Brown, Stephen A ^c   Garvy, Beth A ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e TOURO UNIVERSITY NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; MOUSE; NEWBORN; NONHUMAN; PNEUMOCYSTIS MURINA INFECTION; PNEUMOCYSTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INTERLEUKIN-10; LYMPH NODES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED STRAINS; PNEUMOCYSTIS; PNEUMOCYSTIS INFECTIONS; PULMONARY ALVEOLI; T-LYMPHOCYTES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864802021     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05707-11     Document Type: Article

References (58)

1. Adkins B, Leclerc C, Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564.
2. Alejandre-Alcazar MA, et al. 2008. TGF-_ signaling is dynamically reg-ulated during the alveolarization of rodent and human lungs. Dev. Dynamics 237:259 -269.
3. Beck JM, et al. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859 -3862.
4. Beck JM, et al. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell Mol. Biol. 5:186 -197.
5. Beck JM, Warnock ML, Kaltreider HB, Shellito JE. 1993. Host defenses against Pneumocystis carinii in mice selectively depleted ofCD4_lymphocytes. Chest 103:116s-118s.
6. Belkaid Y, et al. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
7. Bourbon JR. 1999. Gene expression in alveolar development. In Gaultier C, Bourbon JR, Post M (ed), Lung development. American Physiological Society, New York, NY.
8. CDC. 1995. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Morb. Mortal. Wkly. Rep. 44: 1-11.
9. Chen W, Havell EA, Harmsen AG. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279 -1284.
10. Coker RK, et al. 1996. Diverse cellular TGF-_1 and TGF-_3 gene expression in normal human and murine lung. Eur. Respir. J. 9:2501-2507.
11. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. 1989. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J. Immunol. 142:1536 -1541.
12. Empey KM, Hollifield M, Garvy BA. 2007. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice. Infect. Immun. 75:3382-3393.
13. Empey KM, Hollifield M, Schuer K, Gigliotti F, Garvy BA. 2004. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation. Infect. Immun. 72:6211- 6220.
14. Evans SE, et al. 2005. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaBdependent mechanisms. Am. J. Respir. Cell Mol. Biol. 32:490-497.
15. Ezekowitz RA, et al. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
16. Fernandez S, Jose P, Avidiushko MG, Kaplan AM, Cohen DA. 2004. Inhibition of IL-10 receptor function in alveolar macrophages by toll-like receptor agonists. J. Immunol. 172:2613-2620.
17. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
18. Gajdusek DC. 1957. Pneumocystis carinii-etiological agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19: 543-565.
19. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. 2003. Collaborative induction of inflammatory responses by Dectin-1 and Tolllike receptor 2. J. Exp. Med. 197:1107-1117.
20. Garvy BA, Harmsen AG. 1996. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect. Immun. 64:3987-3992.
21. Garvy BA, Qureshi M. 2000. Delayed inflammatory response to Pneumocystis carinii infection in neonatal mice is due to an inadequate lung environment. J. Immunol. 165:6480-6486.
22. Harmsen AG, Stankiewicz M. 1990. Requirement for CD4_ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937-945.
23. Harmsen AG, Stankiewicz M. 1991. T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. J. Protozool. 38:44S- 45S.
24. Hoffman OA, Standing JE, Limper AH. 1993. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150:3932- 3940.
25. Jaskoll T, Choy HA, Melnick M. 1996. The glucocorticoidglucocorticoid receptor signal transduction pathway, transforming growth factor-_, and embryonic mouse lung development in vivo. Pediatr. Res. 39:749 -759.
26. Levy O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379 -390.
27. Li MO, Wan YY, Sanjabi S, Roberston A-KL, Flavell RA. 2006. Transforming growth factor-_ regulation of immune responses. Annu. Rev. Immunol. 24:99 -146.
28. Limper AH, Hoyte JS, Standing JE. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Investig. 99:2110 -2117.
29. Lund FE, Schuer K, Hollifield M, Randall TD, Garvy BA. 2003. Clearance of Pneumocystis carinii in mice is dependent on b cells but not on P. carinii-specific antibody. J. Immunol. 171:1423-1430.
30. Marcotte H, et al. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173:1034 -1037.
31. Mendelson CR. 2000. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu. Rev. Physiol. 62:875- 915.
32. Nakanishi H, Sugiura T, Streisand JB, Lonning SM, Roberts JD, Jr. 2007. TGF-_-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am. J. Physiol. Lung Cell Physiol. 293:L151-L161.
33. Peglow SL, et al. 1990. Serologic responses to Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161:296 -306.
34. Pestka S, et al. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929 -979.
35. Qureshi M, Empey KM, Garvy BA. 2005. Modulation of proinflammatory responses to Pneumocystis carinii f. sp. muris in neonatal mice by granulocyte-macrophage colony-stimulating factor and IL-4: role of APCs. J. Immunol. 174:441- 448.
36. Qureshi MH, Cook-Mills J, Doherty DE, Garvy BA. 2003. TNF-alphadependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii. J. Immunol. 171:4700-4707.
37. Qureshi MH, Garvy BA. 2001. Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia. J. Immunol. 166:5704 -5711.
38. Qureshi MH, Harmsen AG, Garvy BA. 2003. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J. Immunol. 170:1002-1009.
39. Rogers MF, et al. 1987. Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control national surveillance, 1982-1985. Pediatrics 79:1008 -1014.
40. Romani L, et al. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152:3514 -3521.
41. Rose S, Lichtenheld M, Foote MR, Adkins B. 2007. Murine neonatal CD4_ cells are poised for rapid Th2 effector-like function. J. Immunol. 178:2667-2678.
42. Roths JB, Sidman CL. 1992. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4_ but not CD8_ T cells into severe combined immunodeficiency mice. J. Clin. Investig. 90:673- 678.
43. Roths JB, Sidman CL. 1993. Single and combined humoral and cellmediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient SCID mice. Infect. Immun. 61:1641-1649.
44. Saijo S, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:39-46.
45. Shull MM, et al. 1992. Targeted disruption of the mouse transforming growth factor-_1 gene results in multifocal inflammatory disease. Nature 359:393-399.
46. Soltys J, Bonfield T, Chmiel J, Berger M. 2002. Functional IL-10 deficiency in the lung of cystic fibrosis (cftr_/_) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J. Immunol. 168:1903-1910.
47. Steele C, et al. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 _-glucan receptor. J. Exp. Med. 198:1677-1688.
48. Ten Have-Opbroek AAW. 1981. The development of the lung in mammals: an analysis of concepts and findings. Am. J. Anat. 162:201-219.
49. Toossi Z, et al. 1996. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J. Immunol. 156: 3461-3468.
50. Vargas SL, et al. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32:855- 861.
51. Vargas SL, et al. 1999. Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin. Infect. Dis. 29:1489 -1493.
52. Wang J, et al. 2005. Pneumocystis carinii activates the NF-kappa B signaling pathway in alveolar epithelial cells. Infect. Immun. 73:2766 -2777.
53. Wang Y, et al. 2004. Activation of nuclear factor kappa B in vivo selectively protects the murine small intestine against ionizing radiationinduced damage. Cancer Res. 64:6240-6246.
54. Wert SE. 2004. Normal and abnormal structural development of the lung. In Polin RA, Fox WA, Abman SH (ed), Fetal and neonatal physiology, 3rd ed. Saunders, Philadelphia, PA.
55. Willment JA, et al. 2003. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 171:4569-4573.
56. Zhang C, et al. 2006. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74:1857-1864.
57. Zhou D, et al. 1999. A high dose of ionizing radiation induces tissuespecific activation of nuclear factor-_B in vivo. Radiat. Res. 151:703-709.
58. Zhou D, et al. 2001. Effects of NF-_B1 (p50) targeted gene disruption on ionizing radiation-induced NF-_B activation and TNF , IL-1 , IL-1_, and IL-6 mRNA expression in vivo. Int. J. Radiat. Oncol. Biol. Phys. 77: 763-772.